Current Problems in Cardiology
Volume 32, Issue 11 , Pages 609-661 , November 2007

Valvular Heart Disease in the Community: A European Experience

References 

  1. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–1011
  2. Bonow R, Carabello B, DeLeon A, et al. ACC/AHA guidelines for the management of patients with valvular heart disease. Circulation. 1998;98:1949–1984
  3. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol. 2006;48:e1–e148
  4. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease. Eur Heart J. 2007;28:230–268
  5. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J. 2003;24:1231–1243
  6. Tornos P, Iung B, Permanyer-Miralda G, et al. Infective endocarditis in Europe: lessons from the Euro Heart Survey. Heart. 2005;91:571–575
  7. Iung B, Cachier A, Baron G, et al. Decision making in elderly patients with severe aortic stenosis: why are so many denied surgery?. Eur Heart J. 2005;26:2714–2720
  8. Iung B, Messika-Zeitoun D, Cachier A, et al. Actual management of patients with asymptomatic aortic valve disease: how practice fits with guidelines. Am Heart J. 2007;153:696–703
  9. Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?. Eur Heart J. 2007;28:1358–1365
  10. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383
  11. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease: cardiovascular health study. J Am Coll Cardiol. 1997;29:630–634
  12. Rajamannan NM, Gersh B, Bonow RO. Calcific aortic stenosis: from bench to the bedside (Emerging clinical and cellular concepts). Heart. 2003;89:801–805
  13. Rabkin E, Aikawa M, Stone JR, et al. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation. 2001;104:2525–2532
  14. Roberts WC, Ko JM, Hamilton C. Comparison of valve structure, valve weight, and severity of the valve obstruction in 1849 patients having isolated aortic valve replacement for aortic valve stenosis (with or without associated aortic regurgitation) studied at 3 different medical centers in 2 different time periods. Circulation. 2005;112:3919–3929
  15. Rizvi SFH, Khan MA, Kundi A, et al. Current status of rheumatic heart diseases in rural Pakistan. Heart. 2004;90:394–399
  16. Messika-Zeitoun D, Thomson H, Bellamy M, et al. Medical and surgical outcome of tricuspid regurgitation caused by flail leaflets. J Thorac Cardiovasc Surg. 2004;128:296–302
  17. Dare AJ, Vienot JP, Edwards WD, et al. New observations on the etiology of aortic valve disease: a surgical pathologic study of 236 cases from 1990. Hum Pathol. 1993;24:1330–1338
  18. Dare AJ, Harrity PJ, Tazelaar HD, et al. Evaluation of surgically excised mitral valves: revised recommendations based on changing operative procedures in the 1990s. Hum Pathol. 1993;24:1286–1293
  19. Passik CS, Ackermann DM, Pluth JR, et al. Temporal changes in the causes of aortic stenosis: a surgical pathological study of 646 cases. Mayo Clin Proc. 1987;62:119–123
  20. Olsen LJ, Subramanian R, Ackerman DM, et al. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc. 1987;62:22–34
  21. Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220–1225
  22. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162:2269–2276
  23. Butchart EG, Gohlke-Barwolf C, Antunes MJ, et al. Working Groups on Valvular Heart Disease Thrombosis, and cardiac rehabilitation and exercise physiology, European Society of Cardiology Recommendations for the management of patients after heart valve surgery. Eur Heart J. 2005;26:2463–2471
  24. Monin JL, Dehant P, Roiron C, et al. Functional assessment of mitral regurgitation by transthoracic echocardiography using standardized imaging planes. J Am Coll Cardiol. 2005;46:302–309
  25. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2003;42:1318–1333
  26. Omran H, Schmidt H, Hackenbroch M, et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet. 2003;361:1241–1246
  27. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg. 1999;15:816–823
  28. Edwards FH, Peterson ED, Coombs LP, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol. 2001;37:885–892
  29. Hannan EL, Racz MJ, Jones RH, et al. Predictors of mortality for patients undergoing cardiac valve replacement in New York State. Ann Thorac Surg. 2000;70:1212–1218
  30. Ambler G, Omar RZ, Royston P, et al. Generic, simple risk stratification model for heart valve surgery. Circulation. 2005;112:224–231
  31. Lee SJ, Lindquist K, Segal MR, et al. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA. 2006;295:801–808
  32. Kvidal P, Bergström R, Hörte LG, et al. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol. 2000;35:747–756
  33. Sedrakyan A, Vaccarino V, Paltiel AD, et al. Age does not limit quality of life improvement in cardiac valve surgery. J Am Coll Cardiol. 2003;42:1215–1217
  34. Bouma BJ, van den Brink RBA, van der Meulen JHP, et al. To operate or not elderly patients with aortic stenosis: the decision and its consequences. Heart. 1999;82:143–148
  35. Pereira JJ, Lauer MS, Bashir M, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol. 2002;39:1356–1363
  36. Avierinos JF, Gersh BJ, Melton LJ, et al. Natural history of mitral valve prolapse in the community. Circulation. 2002;106:1355–1361
  37. Iung B, Gohlke-Barwolf C, Tornos P, et al. Recommendations on the management of the asymptomatic patient with valvular heart disease (Working Group Report on behalf of the Working Group on Valvular Heart Disease). Eur Heart J. 2002;23:1253–1266
  38. Rahimtoola SH. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol. 2003;41:893–904
  39. Vahanian A, Palacios IF. Percutaneous approaches to valvular disease. Circulation. 2004;109:1572–1579
  40. US Society of Thoracic Surgeons National Database. http://www.sts.org/section/stsdatabase.
  41. National Adult Cardiac Surgical Database Report 1999-2000. The United Kingdom Cardiac Surgical Register. http://www.scts.org/file/NACSDreport2000ukcsr.pdf
  42. Iung B. Management of ischaemic mitral regurgitation. Heart. 2003;89:459–464
  43. Hoen B, Alla F, Béguinot I, et al. Changing profile of infective endocarditis—results of a one-year survey in France in 1999. JAMA. 2002;288:75–81
  44. Delahaye F, Goulet V, Lacassin F, et al. Characteristics of infective endocarditis in France in 1991 (A 1-year survey). Eur Heart J. 1995;16:394–401
  45. Di Salvo G, Thuny F, Rosenberg V, et al. Endocarditis in the elderly: clinical, echocardiographic, and prognostic features. Eur Heart J. 2003;24:1576–1583
  46. Di Salvo G, Habib G, Pergola V, et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol. 2001;37:1069–1076
  47. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary: the Task Force on infective endocarditis of the European Society of Cardiology. Eur Heart J. 2004;25:267–276
  48. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia (American Heart Association Endorsed by the Infectious Diseases Society of America). Circulation. 2005;111:e394–e433
  49. Habib G. Management of infective endocarditis. Heart. 2006;92:124–130

 The Euro Heart Survey on valvular heart disease was funded by the European Society of Cardiology, Dutch Heart Foundation, Fédération Française de Cardiologie/Société Française de Cardiologie, Hellenic Cardiological Society, Swedish Heart and Lung Foundation, European Commission Grant (Infermed/Mansev Project), and Toray Medical Company.

PII: S0146-2806(07)00085-0

doi: 10.1016/j.cpcardiol.2007.07.002

Current Problems in Cardiology
Volume 32, Issue 11 , Pages 609-661 , November 2007

Article Tools

* Image Usage & Resolution